AI Tool Shows Promise in Assessing Severity of Rare Cancer
An exciting study reveals that artificial intelligence (AI) has exhibited an ability almost twice as effective as conventional methods in assessing the aggressiveness of a rare cancer through scans. The AI, discerning details imperceptible to the human eye, demonstrated 82% accuracy in grading cancer’s severity, surpassing the 44% accuracy of lab analysis.